Ajanta Pharma Limited

AJANTPHARM.NS·NSE·Healthcare
Compare
3,282.10−34.60 (−1.04%)today
At close: Nov 5, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close3,316.70
Open3,340.00
Day range3,266.403,350.00
52-week range2,445.803,796.00
Off day high−2.03%
Off 52-week high−13.54%
Volume131.61K
Avg. volume (3M)109.86K
Market cap410.13B
EPS (TTM)101.01
Forward P/E27.91
P/E ratio (TTM)32.49
Dividend yield1.93% (64.00)
Beta (5Y)0.23
Shares outstanding124.96M
Short interest—
Earnings dateJul 28, 2025 (est.)
Analyst target3,879.54
Profit margin20.31%

Against its peers

Compare in full ›
AJANTPHARM.NS AUROPHARMA.NS JUBLPHARMA.NS IPCALAB.NS ASTRAZEN.NS 4553.T
Market cap 410.13B 1.03T 150.02B 494.62B 157.35B 179.68B
P/E (TTM) 32.5 25.9 42.7 37.8 92.8 21.7
Forward P/E 27.9 19.0 18.7 27.7 — 12.4
Price/book 8.4 2.6 2.1 6.1 18.0 1.0
Dividend yield 1.93% — 0.53% 0.30% 0.57% 2.28%
1-year change +29.11% +49.48% −20.53% +51.13% −30.65% +25.13%
Today −1.04% +4.69% +0.80% −1.14% −1.16% +3.84%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Univest·Negative

Ajanta Pharma Share Price Fall Streak After Second Drop

Ajanta Pharma Share Price Fall Streak has now run into a second straight session, with the stock last traded at Rs 3,499.75, down 2.3% for the day, and the company valued at Rs 44,762.82 crore. The price move is confirmed in Univest data;…

From the 4Search news index, newest first.

In the news

1mentions in 30 days
1with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance